OSCR Form 144: 30,000 shares to hit market, minimal dilution

Rhea-AI Filing Summary

Oscar Health, Inc. (OSCR) has filed a Form 144 indicating a planned sale of 30,000 common shares through Morgan Stanley Smith Barney LLC. The shares were acquired as restricted stock units (RSUs) on 06/01/2024 and are slated for sale on or about 06/20/2025 on the NYSE. Based on the stated aggregate market value of $563,100, the implied price is roughly $18.77 per share. With 219.163 million shares outstanding, the transaction represents only about 0.014 % of total shares, suggesting minimal dilution or market impact. No other sales by the filer occurred in the past three months, and no adverse information was disclosed in the notice.

Positive

• Transaction represents only 0.014% of outstanding shares, indicating negligible dilution and limited market impact.

Negative

• Insider share sale, though small, can sometimes be perceived negatively by investors tracking insider sentiment.

Insights

Securities Analyst

TL;DR: Small insider sale (0.014% of OSCR float); limited price impact expected.

The Form 144 covers 30,000 shares, a tiny fraction of Oscar Health's 219 million shares outstanding. The shares stem from RSUs granted and vested on 06/01/2024, so monetization is routine. At the declared $563,100 market value, the sale price aligns with recent trading levels and does not signal valuation concerns. No additional sales in the last quarter and standard Rule 10b5-1 representations reduce the risk of negative perception. Overall, the filing is informational with negligible financial impact.

Corporate Governance Expert

TL;DR: Routine RSU liquidation; governance risk minimal.

The notice shows compliance with Rule 144 and Rule 10b5-1 safeguards, indicating procedural adherence. Lack of material adverse information representation and the small transaction size suggest no governance red flags. Investors should monitor cumulative insider activity, but this single filing, absent further context, is immaterial.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	30000	563100.00	219163000	06/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2024	Restricted Stock Units	Issuer			30000	06/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Oscar Health (OSCR) shares are being sold under this Form 144?

The filing covers 30,000 common shares.

What is the approximate market value of the proposed OSCR stock sale?

The aggregate market value is $563,100.

What percentage of Oscar Health's outstanding shares does 30,000 represent?

Roughly 0.014 % of the 219.163 million shares outstanding.

When were the OSCR shares acquired and how?

They were acquired as restricted stock units on 06/01/2024.

On which exchange and date are the shares expected to be sold?

The sale is targeted for 06/20/2025 on the NYSE.